Mustoe T A, Fried M P, Goodman M L, Kelly J H, Strome M
J Laryngol Otol. 1984 Sep;98(9):929-38. doi: 10.1017/s0022215100147735.
Plasma cell neoplasms have been classified as multiple myeloma, solitary plasmacytoma and extramedullary plasmacytoma. They are usually considered as osteolytic lesions of bone except for the rare occurrence of osteosclerotic lesions. This paper describes the first reported osteosclerotic plasmacytoma of the maxillary bone and orbital floor. The difficulties in establishing a diagnosis and the relationship to other plasma cell neoplasms are discussed. Osteosclerotic plasmacytomas are a rare variant of plasma cell tumors which usually produce osteolytic lesions rather than bony sclerosis. Sixty-eight patients with the osteosclerotic variant have appeared in the world literature, with an overall incidence of about 1 per cent in a large series of plasma cell neoplasms (Dreidger and Pruzanski, 1979). There have been only six previous cases of solitary osteosclerotic plasmacytomas reported (Morley and Schweiger, 1964; Roberts et al., 1974; Rodriguez et al. 1976; Rushton, 1965; Schneinker, 1938; Brigham Medical Review, 1961) involving spine, sternum, or rib. None have previously been reported in the head and neck area. Plasma cell tumors have been classified into multiple myeloma, solitary plasmacytomas of bone, and extramedullary plasmacytomas. Multiple myeloma is a disseminated plasma cell malignancy characterized by the production of homogeneous immunoglobulins (whole or fragments) which appear in the serum and urine. Plasma cell tumors can also occur as solitary plasmacytomas, usually in bone, but also in soft tissue. With time, most solitary plasmacytomas develop disseminated disease with all the characteristics of multiple myeloma (Wiltshaw, 1976). Extramedullary plasmacytomas arise in soft tissue rather than bone, and primarily occur in the head and neck region. Clinically, they remain localized and less frequently develop into disseminated myeloma.
浆细胞肿瘤已被分类为多发性骨髓瘤、孤立性浆细胞瘤和髓外浆细胞瘤。除了罕见的骨硬化性病变外,它们通常被认为是骨的溶骨性病变。本文描述了首例报告的上颌骨和眶底骨硬化性浆细胞瘤。讨论了诊断的困难以及与其他浆细胞肿瘤的关系。骨硬化性浆细胞瘤是浆细胞肿瘤的一种罕见变体,通常产生溶骨性病变而非骨质硬化。世界文献中出现了68例骨硬化性变体患者,在一大系列浆细胞肿瘤中总体发病率约为1%(德赖德格和普鲁赞斯基,1979年)。此前仅报告过6例孤立性骨硬化性浆细胞瘤(莫利和施韦格,1964年;罗伯茨等人,1974年;罗德里格斯等人,1976年;拉什顿,1965年;施内inker,1938年;布里格姆医学评论,1961年),累及脊柱、胸骨或肋骨。此前头颈部区域均未见报告。浆细胞肿瘤已被分为多发性骨髓瘤、骨孤立性浆细胞瘤和髓外浆细胞瘤。多发性骨髓瘤是一种播散性浆细胞恶性肿瘤,其特征是产生出现在血清和尿液中的同源免疫球蛋白(完整或片段)。浆细胞肿瘤也可表现为孤立性浆细胞瘤,通常发生在骨中,但也可发生在软组织中。随着时间的推移,大多数孤立性浆细胞瘤会发展为具有多发性骨髓瘤所有特征的播散性疾病(威尔特肖,1976年)。髓外浆细胞瘤发生于软组织而非骨,主要发生在头颈部区域。临床上,它们保持局限性,较少发展为播散性骨髓瘤。